CD38 and plasma cell myeloma: A further uncertainty, not yet clarified, concerns the likely reinforcement of the CD38-mediated mechanisms by the other ecto-ADPRC CD157, e.g., in multiple myeloma (MM) and in pleural mesothelioma cells [47,94].